Nifty 17176.7 (1.56%)
Sensex 57633.65 (1.56%)
Nifty Bank 36618.4 (2.47%)
Nifty IT 35272.3 (1.13%)
Nifty Financial Services 17979.35 (2.17%)
Adani Ports 744.70 (2.94%)
Asian Paints 3030.35 (-0.26%)
Axis Bank 687.00 (3.60%)
B P C L 387.80 (1.13%)
Bajaj Auto 3286.45 (1.13%)
Bajaj Finance 7103.15 (2.18%)
Bajaj Finserv 17109.00 (1.28%)
Bharti Airtel 698.85 (0.18%)
Britannia Inds. 3474.20 (-0.63%)
Cipla 889.25 (-0.64%)
Coal India 150.65 (1.41%)
Divis Lab. 4624.80 (-0.47%)
Dr Reddys Labs 4520.70 (0.49%)
Eicher Motors 2471.80 (1.13%)
Grasim Inds 1685.55 (1.49%)
H D F C 2817.50 (1.76%)
HCL Technologies 1149.65 (1.15%)
HDFC Bank 1525.70 (1.46%)
HDFC Life Insur. 694.40 (1.49%)
Hero Motocorp 2461.80 (1.73%)
Hind. Unilever 2321.60 (0.65%)
Hindalco Inds. 442.50 (5.02%)
I O C L 120.60 (-0.29%)
ICICI Bank 734.65 (3.54%)
IndusInd Bank 926.65 (1.20%)
Infosys 1711.65 (0.96%)
ITC 220.65 (1.26%)
JSW Steel 660.65 (2.77%)
Kotak Mah. Bank 1937.15 (2.76%)
Larsen & Toubro 1798.10 (0.87%)
M & M 825.95 (0.46%)
Maruti Suzuki 7186.60 (2.04%)
Nestle India 19254.90 (1.25%)
NTPC 125.35 (0.80%)
O N G C 145.90 (1.78%)
Power Grid Corpn 205.80 (1.88%)
Reliance Industr 2381.85 (0.81%)
SBI Life Insuran 1159.15 (0.93%)
Shree Cement 25800.00 (0.73%)
St Bk of India 476.70 (2.45%)
Sun Pharma.Inds. 743.70 (0.89%)
Tata Consumer 760.70 (1.75%)
Tata Motors 481.80 (3.13%)
Tata Steel 1148.80 (3.61%)
TCS 3584.50 (1.36%)
Tech Mahindra 1576.65 (1.60%)
Titan Company 2380.55 (2.38%)
UltraTech Cem. 7299.40 (1.18%)
UPL 726.95 (1.45%)
Wipro 632.40 (1.27%)
Dr. Reddy Labs and Torrent Pharma
Quarterly Results
28/07/2021

Dr. Reddy's Laboratories reported 11.72% growth in net sales at Rs.4,945 crore for the Jun-21 quarter. However, net profits were down -36% at Rs.380 crore on account of a Rs.184 crore asset impairment write-off in the Jun-21 quarter. Global generics sales were higher yoy but the API business was down. For Reddy Labs, the US accounts for 35% of revenues while India and other emerging markets account for 41%.

Dr. Reddy's Laboratories Quarterly Results

Rs in Crore

Jun-21

Jun-20

YOY

Mar-21

QOQ

Total Income (Rs cr)

₹ 4,945

₹ 4,427

11.72%

₹ 4,768

3.71%

Net Profit (Rs cr)

₹ 380

₹ 595

-36.02%

₹ 557

-31.74%

Diluted EPS (Rs)

₹ 22.89

₹ 35.78

 

₹ 33.51

 

Net Margins

7.69%

13.43%

 

11.69%

 

Gross margins at 52.2% was marginally lower than previous quarters. The positive feature of the quarter was R&D expenses at Rs.453 crore or 9.2% of revenues.  For the Jun-21 quarter, the EBITDA margins stood at 20.7% while free cash flows (FCF) was at Rs.680 crore. Indian revenues were driven by COVID drug sales. Net margins for Jun-21 quarter stood at 7.69%; lower than 13.43% in Jun-20 quarter and 11.69% in Mar-21 quarter.
Among brokerages, Axis Securities, HDFC Securities and BNP Paribas have upgraded their price target while ICICI Securities had downgraded Reddy Labs to Hold.

Torrent Pharma Ltd reported 3.79% growth in net sales at Rs.2,134 crore for Jun-21 quarter. Net profit for the Jun-21 quarter was up 2.8% at Rs.330 crore on stable EBITDA margins and gross margins in the India business. During the quarter, Torrent Pharma launched anti-COVID drug, Bariticinib, which is currently under clinical trials for Molnupiravir. India revenues were up 18% at Rs.1,093 crore while the US sales were down -29% at Rs.266 crore. Due to price erosion. Germany grew 5%, Brazil 9% while CRAMS vertical grew 6% yoy.

Torrent Pharma Quarterly Results

Rs in Crore

Jun-21

Jun-20

YOY

Mar-21

QOQ

Total Income (Rs cr)

₹ 2,134

₹ 2,056

3.79%

₹ 1,937

10.17%

Net Profit (Rs cr)

₹ 330

₹ 321

2.80%

₹ 324

1.85%

Diluted EPS (Rs)

₹ 19.53

₹ 18.98

 

₹ 19.16

 

Net Margins

15.46%

15.61%

 

16.73%

 

Torrent Pharma reported gross margins of 72.4% and EBITDA margins of 34% in the Jun-21 quarter. Till June, Torrent Pharma had 54 ANDAs pending for approval with USFDA with 7 tentative approvals in place. Net margins were 15.46% for Jun-21 quarter compared to 15.61% in Jun-20 quarter and 16.73% in Mar-21 quarter.
Among brokerages, Motilal Oswal and ICICI Securities have upgraded their target for Torrent Pharma while BNP Paribas has downgraded its target.
 

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Start Investing Now!

Open Free Demat Account in 5 mins

 
 
There is some issue, try later